Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 6NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 15Carcinoma, Non-Small-Cell Lung 10Prostatic Neoplasms 8Melanoma 8Colorectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Pancreatic Neoplasms 5Multiple Myeloma 5Lung Neoplasms 5Wilms Tumor 4Neoplasms 4Lymphoma, Mantle-Cell 4Lymphoma 4Hematologic Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Burkitt Lymphoma 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Medulloblastoma 3Malignant Solid Neoplasm 3Lymphoma, Non-Hodgkin 3Leukemia, Myeloid, Acute 3Leukemia, Biphenotypic, Acute 3Glioblastoma 3Ependymoma 3Diffuse Intrinsic Pontine Glioma 3Colonic Neoplasms 3Astrocytoma 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Oligodendroglioma × 30 days × Clear all
NCT04978727 2026-06-02

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Children's Oncology Group

Phase 1 Active not recruiting
35 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Ependymoma, Glioblastoma, Medulloblastoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡